title: Question 1 Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
authors: Neonatal Department, Whittington Hospital NHS Trust, London, UK. lucinda.w@doctors.org.uk
authors: Lucinda C
authors: LC
authors: Winckworth
authors: Elizabeth
authors: E
authors: Powell
mesh_terms: D001049:Apnea / Q000188:drug therapy* / Q000523:psychology; D002110:Caffeine / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000209:etiology / Q000517:prevention & control; D002658:Developmental Disabilities / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy* / Q000523:psychology
chemical_list: D000697:Central Nervous System Stimulants; D002110:Caffeine